Supplementary Figure 2 from miR-155 Drives Metabolic Reprogramming of ER&lt;sup&gt;+&lt;/sup&gt; Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors